NYSE:CRLLife Sciences
Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Pullback
Why Charles River Laboratories International Is On Investors’ Radar Today
Charles River Laboratories International (CRL) has drawn fresh attention after a recent pullback, with the stock down about 16% over the past month and 8% year to date.
At a last close of US$185.70 and a value score of 5, the company sits against a backdrop of 2.8% annual revenue growth, alongside net income of US$83.48 million on US$4.02 billion in revenue.
See our latest analysis for Charles River Laboratories...